Differential effect of pretransplant blood transfusions on immune effector and regulatory compartments in HLA-sensitized and nonsensitized recipients

Transplantation

Volumn 90, Issue 11, 2010, Pages 1192-1199

  Eikmans, Michael ^a   Waanders, Marloes M ^a   Roelen, Dave L ^a   Van Miert, Paula P M C ^a   Anholts, Jacqy D H ^a   De Fijter, Hans W ^b   Brand, Anneke ^a   Claas, Frans H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Sanquin Bloedbank Regio Zuidwest Rotterdam   (Netherlands)

Author keywords

Blood transfusion; Cellular immunity; HLA; Immune regulation; Pretransplant

Indexed keywords

AIFM1 PROTEIN; ARACHIDONATE 12 LIPOXYGENASE; AT HOOK TRANSCRIPTION AKNA; BINDING PROTEIN; CD160 ANTIGEN; CD244 ANTIGEN; CD3 ANTIGEN; CD40 LIGAND; CD53 ANTIGEN; DIPEPTIDYL PEPTIDASE IV; EI24 PROTEIN; FOLLISTATIN; FOLLISTATIN LIKE 3 PROTEIN; GA BINDING PROTEIN BETA 2; GALECTIN 1; GAMMA INTERFERON; HLA ANTIBODY; HLA ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 7 RECEPTOR; KRUPPEL LIKE FACTOR 2; LYMPHOCYTE ANTIGEN; MULTIPLE MYELOMA ONCOGENE 1; PHOSPHOLIPASE A2 ACTIVATING PROTEIN; PROTEIN; SH3KBP1 PROTEIN; SIRPG PROTEIN; TADA3L PROTEIN; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLOOD DONOR; BLOOD TRANSFUSION; CD4+ CD25+ T LYMPHOCYTE; CELLULAR IMMUNITY; CLINICAL ARTICLE; FEMALE; GENE ACTIVITY; GENE EXPRESSION; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; MALE; MEMORY T LYMPHOCYTE; MICROARRAY ANALYSIS; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANCY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; SENSITIZATION;

ANTIGENS, CD3; ANTIGENS, CD56; APOPTOSIS; B-LYMPHOCYTES; BLOOD TRANSFUSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-7 RECEPTOR ALPHA SUBUNIT; ISOANTIBODIES; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; MALE; NETHERLANDS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREAS TRANSPLANTATION; PREGNANCY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSPLANTATION TOLERANCE;

EID: 78650365287     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181fa943d     Document Type: Article

References (41)

1. Blumberg N, Heal JM. Immunomodulation by blood transfusion: An evolving scientific and clinical challenge. Am J Med 1996; 101: 299.
2. Meryman HT. Transfusion-induced alloimmunization and immuno-suppression and the effects of leukocyte depletion. Transfus Med Rev 1989; 3: 180.
3. Vamvakas EC, Blajchman MA. Transfusion-related immunomodula-tion (TRIM): An update. Blood Rev 2007; 21: 327.
4. van Twuyver E, Mooijaart RJ, ten Berge I, et al. Pretransplantation blood transfusion revisited. N Engl J Med 1991; 325: 1210.
5. Bayle F,MassonD, Zaoui P, et al. Beneficial effectofone HLA haplo- or semi-identical transfusion versus three untyped blood units on alloim-munization and acute rejection episodes in first renal allograft recipients. Transplantation 1995; 59: 719.
6. Persijn GG, van Hooff JP, Kalff MW, et al. Effect of blood transfusions and HLA matching on renal transplantation in the Netherlands. Transplant Proc 1977; 9: 503.
7. Opelz G, Graver B, Terasaki PI. Induction of high kidney graft survival rate by multiple transfusion. Lancet 1981; 1: 1223.
8. Jovicic S, Lezaic V, Simonovic R, et al. Beneficial effects of donor-specific transfusion on renal allograft outcome. Clin Transplant (in press).
9. Lagaaij EL, Hennemann IP, Ruigrok M, et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med 1989; 321: 701.
10. Waanders MM, Roelen DL,DeFijter JW,et al. Protocolled blood transfusions in recipients of a simultaneous pancreas-kidney transplant reduce severe acute graft rejection. Transplantation 2008; 85: 1668.
11. Kalechman Y, Gafter U, Sobelman D, et al. The effect of a single whole-blood transfusion on cytokine secretion. J Clin Immunol 1990; 10: 99.
12. Quigley RL, Wood KJ, Morris PJ. Transfusion induces blood donor-specific suppressor cells. J Immunol 1989; 142: 463.
13. + regulatory T cells: A potential explanation for the blood-transfusion effect. Transplantation 2003; 76: 449.
14. Pirenne J, Kitade H, Kawai M, et al. Regulatory cells, TH1/TH2 unbalance, and antibody-induced chronic rejection in operational tolerance induced by donor-specific blood transfusion. Transplantation 2005; 79: S25.
15. Cavinato RA, Casiraghi F, Azzollini N, et al. Pretransplant donor peripheral blood mononuclear cells infusion induces transplantation tolerance by generating regulatory T cells. Transplantation 2005; 79:1034.
16. Claas FH, de Koster HS, Lagaaij EL, et al. A molecular mechanism of T cell downregulation by blood transfusion. Exp Nephrol 1993; 1: 134.
17. Waanders MM, Roelen DL, Brand A, et al. The putative mechanism of the immunomodulating effect of HLA-DR shared allogeneic blood transfusions on the alloimmune response. Transfus Med Rev 2005; 19: 281.
18. Eisenberger U, Seifried A, Patey N, et al. FoxP3 positive T cells in graft biopsies from living donor kidney transplants after donor-specific transfusions. Transplantation 2009; 87: 138.
19. Camby I, Le MM, Lefranc F, et al. Galectin-1: A small protein with major functions. Glycobiology 2006; 16: 137R
20. + T cells. Blood 2007; 109: 2058.
21. Yusuf I, Fruman DA. Regulation of quiescence in lymphocytes. Trends Immunol 2003; 24: 380.
22. Kawabata D, Tanaka M, Fujii T, et al. Ameliorative effects of follistatin-related protein/TSC-36/FSTL1 on joint inflammation in a mouse model of arthritis. Arthritis Rheum 2004; 50: 660.
23. Buckley AF, Kuo CT, Leiden JM. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc-dependent pathway. Nat Immunol 2001; 2: 698.
24. Jing X, Zhao DM, Waldschmidt TJ, et al. GABPbeta2 is dispensible for normal lymphocyte development but moderately affects B cell responses. J Biol Chem 2008; 283: 24326.
25. Kuhn H, O'Donnell VB. Inflammation and immune regulation by 12/ 15-lipoxygenases. Prog Lipid Res 2006; 45: 334.
26. Mittrucker HW, Matsuyama T, Grossman A, et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 1997; 275: 540.
27. Siddiqa A, Sims-Mourtada JC, Guzman-Rojas L, et al. Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA Nature 2001; 410: 383.
28. Kaplan J, Sarnaik S, Gitlin J, et al. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984; 64: 308.
29. Jensen LS, Andersen AJ, Christiansen PM, et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992; 79: 513.
30. Ljunggren HG, Karre K. In search of the 'missing self: MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237.
31. Kitade H, Kawai M, Rutgeerts O, et al. Early presence of regulatory cells in transplanted rats rendered tolerant by donor-specific blood transfusion. J Immunol 2005; 175: 4963.
32. Abe Y, Urakami H, Ostanin D, et al. Induction of Foxp3-expressing regulatory T-cells by donor blood transfusion is required for tolerance to rat liver allografts. PLoS ONE 2009; 4: e7840.
33. + natural regulatory T cells revealed by DNA microarray analysis. Int Immunol 2006; 18: 1197.
34. Blois SM, Ilarregui JM, Tometten M, et al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007; 13: 1450.
35. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004; 4: 665.
36. Hoyer KK, Dooms H, Barron L, et al. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 2008; 226: 19.
37. Lin L, Hron JD, Peng SL. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 2004; 21: 203.
38. Le Luduec JB, Condamine T, Louvet C, et al. An immunomodulatory role for follistatin-like 1 in heart allograft transplantation. Am J Transplant 2008; 8: 2297.
39. Claas FH, Doxiadis II. Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant. Hum Immunol 2009; 70: 636.
40. van den Boogaardt DE, van Miert PP, de Vaal YJ, et al. The ratio of interferon-gamma and interleukin-10 producing donor-specific cells as an in vitro monitoring tool for renal transplant patients. Transplantation 2006; 82: 844.
41. Heidt S, Roelen DL, Eijsink C, et al. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol 2010; 159: 199.